Company profile
UK company SC418838, incorporated on 7 March 2012.
Clyde Bio | Cardiomyocyte Assay | Flipr Assay
Clyde Biosciences CellOPTIQ platform is the leading cardiomyocyte assay for safety and efficacy. Helping to bring better, safer drugs to market, we're an official member of CiPA
Company number SC418838
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
1 Sep 2014 to 31 Mar 2016
Printing tissues and mini-organs has recently been achieved by using modified ink-jet printer technology in the field of biofabrication. The novel method of direct printing live cells opens up new paradigm in tissue science for drug discovery and therapeutic applications. This project aims to develop the first commercial stem cell bioprinter based on the ...
1 Jul 2013 to 31 Oct 2013
The pharmaceutical industry is in urgent need of tests that are better able to predict the clinical effectiveness and safety of new drug therapies. Current approaches are over-reliant on animal models that may not reflect human responses to drugs and often do not select drugs that translate into safe, effective treatment of diseases. Indeed around 90% of ...
